Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06847230 · ClinicalTrials.gov registry record · NA
How Does DT1 Sphere Perform in Current and Successful Acuvue MAX Wearers?
A NA study, sponsored by Southern College of Optometry.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT06847230 is a NA study that has completed, run by Southern College of Optometry. The registered enrollment target is 36 participants.
The verdict
NCT06847230, a NA study, has completed, sponsored by Southern College of Optometry.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The goal of this prospective study is to to understand if satisfied MAX Contact lens (CL)wearers can be successfully refit into Dailies total 1 (DT1) CL in healthy MAX CL wearers between the ages of 18-40. The main question is to determine the number of participants who can successfully be re-fit into DT1 CL, by utilizing a cldeq-8 questionnaire as well as an investigator developed questionnaire to gauge comfort and satisfaction.
Interventions
- DEVICE Dailies total 1 contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06847230
The ClinicalTrials.gov registry entry for NCT06847230 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern College of Optometry, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dailies total 1 contact lenses is the first listed.
NCT06847230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06847230 about?
NCT06847230 is a clinical study titled "How Does DT1 Sphere Perform in Current and Successful Acuvue MAX Wearers?". The goal of this prospective study is to to understand if satisfied MAX Contact lens (CL)wearers can be successfully refit into Dailies total 1 (DT1) CL in healthy MAX CL wearers between the ages of 18-40. The main question is to determine the number of participants who can successfully be re-fit in...
What is the current status of trial NCT06847230?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2024-07-15. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT06847230?
The interventions under investigation include: Dailies total 1 contact lenses (DEVICE).
Who is sponsoring clinical trial NCT06847230?
This trial is sponsored by Southern College of Optometry, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.